Summit Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Unregistered Sales of Equity Securities, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits